Download - Emerging data with immunotherapy in ESCC and potential impact for clinical practice

Discover

Podcast Features
Your all-in-one podcasting solution.

Podcast Studio
Easy-to-use audio recorder app.
Livestream
High-performing audio live, without limits.

Podcast App
The best podcast player & podcast app.
Podbean AI
AI-Enhanced Audio Quality and Content Generation.

Ads Marketplace
Join Ads Marketplace to earn money
through sponsorship on your podcast.

PodAds
Manage your ads with dynamic ad insertion capability.
Patron & Paid Content
The seamless way for fans to support you directly
from your podcast.
Apple Podcasts Subscriptions Integration
Effortlessly publish and manage exclusive episodes for your
Apple Podcasts subscribers directly from Podbean.

All Arts Business Comedy Education
Fiction Government Health & Fitness History Kids & Family
Leisure Music News Religion & Spirituality Science
Society & Culture Sports Technology True Crime TV & Film
Live

How to Start a Podcast
How to Start a Live Podcast
How to Monetize a podcast
How to Promote Your Podcast
How to Use Group Recording

Log in
Start your podcast for free

Podcasting
Monetization
Enterprise
Pricing
Discover

touchPODCAST

Science

Emerging data with immunotherapy in ESCC and potential impact for clinical practice

2023-03-09

Download

touchTALKS for touchONCOLOLOGY

Listen to a leading expert discussing the recent developments in esophageal cancer with a primary focus on esophageal squamous cell carcinoma (ESCC)

The expert:

Dr Elizabeth Smyth, Addenbrooke’s Hospital, Cambridge, UK

Overview:

Part 1: Insights from 2021 (0:00)
Part 2: Insights from ASCO and ESMO GI 2022 (13:29)
Part 3: Insights from the updated ESMO Clinical Practice Guideline (24:08)
Part 4: Insights from ESMO Asia 2022 and ASCO GI 2023 (34:53)

This touchPODCAST is for HCPs only.

Funding for this touchPODCAST is from an independent medical education grant from Novartis. This activity is provided by touchIME.

For further information please visit: https://touchoncologyime.org/congress-renal-cell-carcinoma-asco-gu-2023